TissueCypher - Barrett's Esophagus reposted this
This powerful tool can help patients with Barrett's Esophagus avoid cancer - and unnecessary surveillance. It should also allow them to rest easier. Researchers won the President's Award at the American College of Gastroenterology Annual Scientific Meeting for their work examing TissueCypher by Castle Biosciences, Inc.
➡️ Reducing the Risk of Esophageal Cancer by 60%! Research presented this week at the American College of Gastroenterology Annual Scientific Meeting shows that when TissueCypher test results guide the treatment of patients with Barrett's Esophagus, the risk of Esophageal Adenocarcinoma-related deaths can be reduced by nearly 60%. The study found that treatment guided by the test can produce a 58.4% reduction in the incidence of High-Grade Dysplasia and Esophageal Adenocarcinoma. The TissueCypher Barrett’s Esophagus test from Castle BioSciences is a precision medicine test designed to predict future development of high-grade dysplasia (HGD) and/or Esophageal Cancer in patients with Barrett’s esophagus (BE). The TissueCypher Barrett’s Esophagus test is indicated for use in patients with endoscopic biopsy-confirmed BE that is graded non-dysplastic (NDBE), indefinite for dysplasia (IND) or low-grade dysplasia (LGD); See the award-winning poster here: https://lnkd.in/eWszbMh3 Learn how TissueCypher works: https://lnkd.in/e4GPq65p